Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices

被引:0
|
作者
Tie, Hongtao [1 ,2 ]
Li, Zhenhan [3 ,4 ]
Welp, Henryk [1 ]
Guha, Avirup [5 ,6 ]
Caraballo, Cesar [7 ,8 ]
Deschka, Heinz [1 ]
Shi, Rui [9 ]
Zheng, Xiaoqing [10 ]
Martens, Sven [1 ]
Sindermann, Jurgen [1 ]
Chen, Dan [2 ]
Wu, Qingchen [2 ]
Martens, Sabrina [1 ]
机构
[1] Univ Hosp Muenster, Dept Cardiothorac Surg, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Chongqing, Peoples R China
[3] Chongqing Tradit Chinese Med Hosp, Dept Endocrinol, Chongqing, Peoples R China
[4] Univ Hosp Muenster, Dept Anaesthesiol Intens Care Med & Pain Med, Munster, Germany
[5] Augusta Univ, Med Coll Georgia, Dept Internal Med, Div Cardiol, Augusta, GA USA
[6] Ohio State Univ, Med Ctr, Cardiooncol Program, Div Cardiol, Columbus, OH USA
[7] Yale Sch Med, Sect Cardiovasc Med, New Haven, CT USA
[8] Ctr Outcomes Res & Evaluat, New Haven, CT USA
[9] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Crit Care Med, Guangzhou, Peoples R China
[10] Univ Pittsburgh, Pittsburgh, PA USA
来源
ESC HEART FAILURE | 2024年 / 11卷 / 01期
关键词
Calcium channel blocker; LVAD; Survival; Adverse events; WORSENING RENAL-FUNCTION; CHRONIC HEART-FAILURE; EJECTION FRACTION; TRANSPLANTATION; ASSOCIATION; AMLODIPINE; SOCIETY; RISK;
D O I
10.1002/ehf2.14576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsCurrent guidelines suggest calcium channel blockers (CCBs) as the second or third option for blood pressure management in patients with left ventricular assist device (LVAD). However, the clinical outcomes of patients with LVAD who receive CCBs remain unclear. Our study aims to analyse the association of CCBs with clinical outcomes in patients after LVAD implantation.Methods and resultsThis is a retrospective analysis based on the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) from 2006 to 2017, and adult patients who were alive with LVAD and CCB treatment information at 6 months after implantation were included. Among 10 717 patients, 1369 received CCBs 6 months after implantation, and there was an increasing trend of CCB use after LVAD. Patients receiving CCB therapy at 6 months had a similar 5 year survival rate to those not receiving CCB [49.6%, 95% confidence interval (CI): 47.5-51.7% vs. 51.1%, 95% CI: 45.3-56.7%]. In both Cox and competing risk regressions after adjusting for confounding factors, CCB treatment at 6 months after implantation was not associated with long-term mortality [hazard ratio (HR): 1.03, 95% CI: 0.91-1.17, P = 0.624 and subdistribution HR (SHR): 1.07, 95% CI: 0.95-1.22, P = 0.260]. Consistently, in time-varying models, CCB treatment was not linked to long-term mortality (HR: 0.97, 95% CI: 0.87-1.09, P = 0.682 and SHR: 1.05, 95% CI: 0.94-1.18, P = 0.359). This null association remained in subgroup analysis according to device strategy and propensity-matching analyses. Neurological dysfunction, stroke, bleeding, rehospitalization, and renal dysfunction were more likely to occur among those with CCB when compared with those without CCB treatment.ConclusionsIn patients with LVAD, CCB therapy fails to show benefits in long-term survival and is associated with increased incidences of neurological dysfunction, bleeding, renal dysfunction, and rehospitalization.
引用
收藏
页码:271 / 281
页数:11
相关论文
共 50 条
  • [1] Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes
    Nguyen, Ann B.
    Imamura, Teruhiko
    Besser, Stephanie
    Rodgers, Daniel
    Chung, Ben
    Raikhelkar, Jayant
    Kalantari, Sara
    Smith, Bryan
    Sarswat, Nitasha
    LaBuhn, Colleen
    Jeevanandam, Valluvan
    Kim, Gene
    Sayer, Gabriel
    Uriel, Nir
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [2] Ventricular Arrhythmias in Patients With Continuous-flow Left Ventricular Assist Devices
    Kuten, David
    McLean, Rhondalyn
    Russell, Stuart
    CIRCULATION, 2013, 128 (22)
  • [3] Ventricular arrhythmias in patients with continuous-flow left ventricular assist devices
    Gkouziouta, A. Aggeliki
    Bonios, M.
    Zarkalis, D.
    Adamopoulos, S.
    Kogerakis, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 75 - 75
  • [4] Trauma in Patients With Continuous-Flow Left Ventricular Assist Devices
    Sarsam, Sinan H.
    Meyers, Deborah E.
    Civitello, Andrew B.
    Agunanne, Enoch E.
    Odegaard, Peggy
    Cohn, William E.
    Frazier, O. H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (09): : 1520 - 1522
  • [5] Impact of Cardiac Resynchronization Therapy on Clinical Outcomes in Patients With Continuous-Flow Left Ventricular Assist Devices
    Gopinathannair, Rakesh
    Birks, Emma J.
    Trivedi, Jaimin R.
    Mccants, Kelly C.
    Sutton, Brad S.
    Deam, Allen G.
    Slaughter, Mark S.
    Hottigoudar, Raseimi U.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (03) : 226 - 232
  • [6] Outcomes from a recovery protocol for patients with continuous-flow left ventricular assist devices
    Knierim, Jan
    Heck, Roland
    Pieri, Marina
    Schoenrath, Felix
    Soltani, Sajjad
    Stawowy, Philipp
    Dreysse, Stephan
    Stein, Julia
    Mueller, Marcus
    Mulzer, Johanna
    Dandel, Michael
    Falk, Volkmar
    Krabatsch, Thomas
    Potapov, Evgenij
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : 440 - 448
  • [7] The Physiology of Continuous-Flow Left Ventricular Assist Devices
    Lim, Hoong Sern
    Howell, Neil
    Ranasinghe, Aaron
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (02) : 169 - 180
  • [8] Endothelial Function in Patients With Continuous-Flow Left Ventricular Assist Devices
    Poredos, Pavel
    Jezovnik, Mateja K.
    Radovancevic, Rajko
    Gregoric, Igor D.
    ANGIOLOGY, 2021, 72 (01) : 9 - 15
  • [9] Clinical Outcomes Associated With Chronic Antimicrobial Suppression Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices
    Jennings, Douglas L.
    Chopra, Anuvrat
    Chambers, Rachel
    Morgan, Jeffrey A.
    ARTIFICIAL ORGANS, 2014, 38 (10) : 875 - U104
  • [10] Characteristics of the Electrocardiogram in Patients with Continuous-Flow Left Ventricular Assist Devices
    Martinez, Sara C.
    Fansler, Derrick
    Lau, Jeffrey
    Novak, Eric L.
    Joseph, Susan M.
    Kleiger, Robert E.
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2015, 20 (01) : 62 - 68